Literature DB >> 6647201

A comparison between atenolol and metoprolol in respect of central nervous system side effects.

C A Kirk, R Cove-Smith.   

Abstract

A double-blind crossover study was performed to compare the incidence of central nervous system (CNS) side effects with atenolol and metoprolol. Eleven women and 6 men who had previously developed such side effects on lipophilic beta-blockers were identified by means of a preliminary questionnaire. A 30-item psychiatric questionnaire was then used to detect changes in psychological status and possible CNS side effects. Discontinuation of the original lipophilic beta-blocker produced a significant improvement in quality of sleep, dreams, concentration, memory, energy and anxiety. Introduction of atenolol did not result in any significant CNS effects. With metoprolol, however, some effects occurred but not to the extent experienced prior to study on other more lipophilic beta-blockers. Blood pressure control was identical with both drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6647201      PMCID: PMC2417444     

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.

Authors:  E S Dimenäs; C G Dahlöf; B Heibel; R G Moore; B K Olofsson; G E Westergren; P W Lücker
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.

Authors:  E Dimenäs; C Dahlöf; B Olofsson; I Wiklund
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

3.  Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.

Authors:  A Westerlund
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Formulary considerations in selection of beta-blockers.

Authors:  K C Yedinak
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

5.  Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism.

Authors:  W Kirch; H Spahn; N R Kitteringham; H J Hutt; E Mutschler; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 6.  Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.

Authors:  M Archer; N Dogra; Z Dovey; T Ganta; H-S Jang; J A Khusid; A Lantz; M Mihalopoulos; J A Stockert; A Zahalka; L Björnebo; S Gaglani; M R Noh; S A Kaplan; R Mehrazin; K K Badani; P Wiklund; K Tsao; D J Lundon; N Mohamed; F Lucien; B Padanilam; M Gupta; A K Tewari; N Kyprianou
Journal:  Cell Commun Signal       Date:  2021-07-20       Impact factor: 5.712

7.  Metoprolol-induced visual hallucinations: a case series.

Authors:  Jonathan A Goldner
Journal:  J Med Case Rep       Date:  2012-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.